A Phase I Study of Gene Therapy of Cystic Fibrosis Utilizing 
a Replication Deficient Recombinant Adenovirus Vector to 
Deliver the Human Cystic Fibrosis Transmembrane 
Conductance Regulator cDNA to the Airways. 
: 
Submitted to the NIH Recombinant DNA Advisory Committee 
January 4, 1993 
i 
Children’s Hospital Medical Center 
Elland & Bethesda Avenues 
Cincinnati, Ohio 45229 
Children's Hospital Medical Center 
Elland and Bethesda Aves., Cincinnati, Ohio 45229-2899 
University of Cincinnati 
College of Medicine 
231 Bethesda Avenue 
Cincinnati, Ohio 45267-0526 
Recombinant DNA Research, Volume 17 
[355] 
